ImmunoRx Pharma
Wilmington, US · Founded 2020 · Delaware corporation · 1 known investors
Find your way into ImmunoRx Pharma
Sign up to see every warm intro you have to ImmunoRx Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ImmunoRx Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
CF
Caroline FortierNamed on SEC filing
MC
Mark CiprianoNamed on SEC filing
MR
Marc RiviereNamed on SEC filing
PT
Philippe TessierNamed on SEC filing
AL
Alexandre LebeautNamed on SEC filing
Investors · 1
TVM Life Science Innovation SCSpreportedSenningerberg
How we know: funding news · press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$2.7M disclosed across 1 round · 2020
▶$2.7MraisedFeb 2021 · 2 investors · PharmaceuticalsRule 506(b)
▶$2.7MraisedFeb 2021 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Caroline FortierExecutive Officer
- Mark CiprianoExecutive Officer
- Marc RiviereDirector
- Philippe TessierDirector
- Alexandre LebeautDirector
- Offering amount
- $25.4M
- Amount sold
- $2.7M
- Proceeds to insiders
- $86K
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are ImmunoRx Pharma's investors?
- ImmunoRx Pharma's investors include TVM Life Science Innovation SCSp.
- How much funding has ImmunoRx Pharma raised?
- ImmunoRx Pharma has disclosed $2.7M raised across 1 round.
- Where is ImmunoRx Pharma headquartered?
- ImmunoRx Pharma is headquartered in Wilmington, US.